Profile data is unavailable for this security.
About the company
Jeena Sikho Lifecare Limited is an ayurvedic healthcare company. The Company is engaged in trading ayurvedic medicine and providing ayurvedic therapy. It provides a wide selection of Ayurvedic products that address every aspect of healthcare, from a healthy lifestyle to more serious conditions. Its products are manufactured under the brand, including Shuddhi, which provides ayurvedic herbs and products for the majority of diseases. Its products include Dr Shuddhi Package (Shuddhi Kit), a detox package, Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani Anti-Viral, which boosts immunity and fight against infections and germs. It also sells items under various brands, such as CAN-TAME, Ca-Nor, and Origine Naturespired, which sells wellness and beauty products. The company also offers yoga classes and various health check-up camps. It provides a range of treatments for different medical issues.
- Revenue in INR (TTM)6.19bn
- Net income in INR1.54bn
- Incorporated2017
- Employees3.76k
- LocationJeena Sikho Lifecare LtdSCO 11 First FloorKalgidha, Enclave, ZirakpurMOHALI 140604IndiaIND
- Websitehttps://jeenasikho.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Supriya Lifescience Ltd | 7.15bn | 1.82bn | 53.86bn | 515.00 | 29.49 | 4.98 | 26.08 | 7.54 | 22.70 | 22.70 | 88.92 | 134.41 | 0.6452 | 1.63 | 5.48 | 13,876,970.00 | 16.47 | 18.45 | 17.73 | 21.63 | 71.44 | 59.62 | 25.52 | 25.45 | 4.37 | 126.22 | 0.0048 | 3.59 | 22.11 | 17.45 | 57.80 | 20.69 | 45.94 | -- |
| F D C Ltd | 20.77bn | 2.25bn | 59.99bn | 6.86k | 26.60 | 2.47 | 21.09 | 2.89 | 13.85 | 13.85 | 127.73 | 149.34 | 0.7455 | 1.78 | 12.30 | 3,029,664.00 | 8.09 | 11.35 | 9.27 | 12.96 | 67.46 | 60.85 | 10.85 | 14.75 | 1.84 | 48.84 | 0.0085 | 6.34 | 8.50 | 9.42 | -12.59 | 2.15 | 25.37 | -- |
| Shilpa Medicare Ltd | 13.42bn | 1.37bn | 61.78bn | 898.00 | 45.02 | 2.54 | 24.36 | 4.61 | 7.02 | 7.02 | 68.61 | 124.61 | 0.4058 | 0.9867 | 3.41 | 14,939,110.00 | 4.15 | 2.02 | 5.14 | 2.61 | 71.63 | 60.07 | 10.23 | 5.17 | 0.7867 | 4.09 | 0.1957 | 9.89 | 11.71 | 7.22 | 145.63 | -12.90 | 16.09 | -- |
| Akums Drugs and Pharmaceuticals Ltd | 41.08bn | 3.17bn | 68.42bn | 7.54k | 21.58 | 2.17 | 14.18 | 1.67 | 20.71 | 20.71 | 268.25 | 205.66 | 0.8712 | 3.69 | 4.85 | 5,450,531.00 | 6.86 | -- | 8.82 | -- | 41.18 | -- | 7.87 | -- | 3.18 | 4.98 | 0.0277 | -- | -1.44 | -- | 8,481.07 | -- | -- | -- |
| Aarti Pharmalabs Ltd | 19.06bn | 2.40bn | 70.41bn | 2.16k | 29.37 | 3.44 | 21.13 | 3.69 | 26.45 | 26.45 | 210.27 | 225.75 | 0.6309 | 1.39 | 4.22 | 8,812,209.00 | 7.94 | -- | 10.54 | -- | 51.04 | -- | 12.58 | -- | 0.8706 | 9.62 | 0.2435 | -- | 14.17 | -- | 25.59 | -- | -- | -- |
| Blue Jet Healthcare Ltd | 11.79bn | 3.52bn | 71.37bn | 491.00 | 20.25 | 5.68 | 19.10 | 6.05 | 20.32 | 20.32 | 68.01 | 72.39 | 0.8706 | 2.87 | 4.51 | 24,013,560.00 | 26.02 | -- | 31.72 | -- | 54.32 | -- | 29.89 | -- | 3.29 | 78.01 | 0.0162 | -- | 44.74 | -- | 86.38 | -- | -- | -- |
| Sudeep Pharma Ltd | -100.00bn | -100.00bn | 72.19bn | -- | -- | 9.97 | -- | -- | -- | -- | -- | 64.13 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.74 | -- | 0.1619 | -- | 9.40 | -- | 4.19 | -- | -- | -- |
| Strides Pharma Science Ltd | 47.26bn | 5.11bn | 79.63bn | 3.30k | 15.57 | -- | 10.93 | 1.69 | 55.49 | 55.49 | 512.73 | -- | -- | -- | -- | 14,315,680.00 | -- | -0.6014 | -- | -1.09 | 59.34 | 50.33 | 11.23 | -1.06 | -- | 8.50 | -- | -- | 17.36 | 10.65 | 437.22 | 52.50 | 10.08 | -22.16 |
| Marksans Pharma Ltd | 28.03bn | 3.60bn | 80.37bn | 1.35k | 22.29 | -- | 17.52 | 2.87 | 7.96 | 7.96 | 61.92 | -- | -- | -- | -- | 20,780,450.00 | -- | 14.15 | -- | 17.41 | 56.77 | 51.56 | 12.90 | 14.58 | -- | 20.42 | -- | 7.77 | 20.46 | 18.25 | 21.32 | 26.60 | 23.73 | 51.57 |
| Procter & Gamble Health Ltd | 12.84bn | 3.07bn | 86.15bn | 1.33k | 28.11 | 13.90 | 26.17 | 6.71 | 184.66 | 184.66 | 772.89 | 373.35 | -- | -- | -- | 9,686,425.00 | -- | -- | -- | -- | 73.77 | -- | 23.89 | -- | 2.30 | 754.85 | 0.0099 | -- | -- | -- | -- | -- | -- | -- |
| Viyash Scientific Ltd | 16.58bn | 418.08m | 87.92bn | 1.24k | 123.36 | 6.24 | 74.69 | 5.30 | 1.63 | 1.63 | 64.36 | 32.32 | 1.01 | 2.18 | 4.34 | 13,327,330.00 | 3.29 | 0.4014 | 5.01 | 0.6553 | 48.74 | 42.16 | 3.26 | 0.4199 | 1.08 | 2.25 | 0.3561 | 995.91 | 13.26 | 5.64 | 160.99 | -20.73 | -0.126 | -- |
| Jeena Sikho Lifecare Ltd | 6.19bn | 1.54bn | 88.54bn | 3.76k | 57.60 | 25.04 | 49.72 | 14.30 | 12.37 | 12.37 | 49.75 | 28.45 | 1.53 | 4.18 | 7.99 | 1,644,723.00 | 37.92 | 32.29 | 46.06 | 40.74 | 91.31 | 92.07 | 24.86 | 16.78 | 2.14 | 33.36 | 0.231 | -- | 44.59 | 37.80 | 31.10 | 73.77 | 47.62 | -- |
| Sanofi India Ltd | 19.33bn | 3.56bn | 92.14bn | 991.00 | 25.86 | -- | 23.40 | 4.77 | 154.71 | 154.71 | 839.09 | -- | -- | -- | -- | 19,500,500.00 | -- | 22.31 | -- | 31.44 | 51.42 | 54.10 | 18.44 | 21.53 | -- | 321.27 | -- | 132.73 | 0.8567 | -8.10 | -13.96 | -5.41 | -13.65 | 1.99 |
| Corona Remedies Ltd | 13.44bn | 1.71bn | 94.02bn | 4.57k | 54.88 | -- | 45.00 | 7.00 | 28.01 | 28.01 | 219.70 | -- | -- | -- | -- | 2,980,876.00 | -- | -- | -- | -- | 81.28 | -- | 12.75 | -- | -- | 55.10 | -- | -- | 17.93 | -- | 65.11 | -- | -- | -- |
| Sanofi Consumer Healthcare India Ltd | 8.16bn | 2.18bn | 97.93bn | 583.00 | 44.94 | -- | 43.10 | 12.00 | 94.62 | 94.62 | 354.49 | -- | -- | -- | -- | 14,003,430.00 | -- | -- | -- | -- | 75.05 | -- | 26.69 | -- | -- | 143.16 | -- | -- | 30.45 | -- | 9.76 | -- | -- | -- |
| Alivus Life Sciences Ltd | 25.12bn | 5.44bn | 114.45bn | 2.20k | 21.08 | -- | 18.61 | 4.56 | 44.23 | 44.23 | 204.37 | -- | -- | -- | -- | 11,403,810.00 | -- | 17.43 | -- | 23.95 | 57.08 | 53.29 | 21.64 | 20.24 | -- | 133.39 | -- | 27.09 | 4.54 | 9.20 | 3.13 | 9.18 | 26.57 | -- |
Data as of Feb 10 2026. Currency figures normalised to Jeena Sikho Lifecare Ltd's reporting currency: Indian Rupee INR
0.06%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Mackenzie Investments Corp. (United States)as of 30 Nov 2025 | 73.69k | 0.06% |
Data from 30 Nov 2025 - 30 Nov 2025Source: FactSet Research Systems Inc.
